Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators

Human adenovirus (HAdV) can cause severe disease in certain at-risk populations such as newborns, young children, the elderly and individuals with a compromised immune system. Unfortunately, no FDA-approved antiviraldrug is currently available for the treatment of HAdV infections. Within the nucleus...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Bratati, Parks, Robin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382930/
https://www.ncbi.nlm.nih.gov/pubmed/33032802
http://dx.doi.org/10.1016/j.virol.2020.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382930/
https://www.ncbi.nlm.nih.gov/pubmed/33032802
http://dx.doi.org/10.1016/j.virol.2020.07.007

Ejemplares similares